Category: Drug Discovery
Global Drug Discovery
-
Global Stem Cells Market Size study & Forecast, by Product (Adult Stem Cells (ASCs), Human Embryonic Stem Cells (HESCs), Induced Pluripotent Stem Cells (iPSCs), Very Small Embryonic Like Stem Cells), By Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion and Sub-Culture), By Therapy (Autologous, Allogenic), By Application (Regenerative Medicine, Drug Discovery and Development), By End-user (Pharmaceutical and Biotechnology Companies, Hospitals & Cell Banks, Academic & Research Institutes), and Regional Analysis, 2022-2029
... Production, Cryopreservation, Expansion and Sub-Culture), By Therapy (Autologous, Allogenic), By Application (Regenerative Medicine, Drug Discovery and Development), By End-user (Pharmaceutical and Biotechnology Companies, Hospitals & Cell Banks, Academic & Research Institutes), and Regional Analysis, 2022-2029 ... Read More
-
DTP Vaccines Global Market Opportunities And Strategies To 2031
... need to assess the global DTP Vaccines market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering ... Read More
-
Microbiome Therapeutics: Global Markets
... Inc. Pylum Biosciences Inc. Quorum Innovations Llc Rebiotix Inc. (A Ferring Company) Second Genome Senda Biosciences Inc. Seres Therapeutics Inc. Sfa Therapeutics Inc. Synlogic Theriva Biologics Inc. Vedanta Biosciences Inc. Ysopia Bioscience Inc.Report Scope: BCC ... Read More
-
Virus-Like Particles (VLP’s) Market Analysis And Forecast To 2032: By Product Type (Hepatitis, Cancer/HPV, Gaucher Disease), Source (Yeast, Insect Cell, Plant, Others), Application (Vaccine, Therapeutics), And Region
... period. Virus-like particles (VLPs) are multiprotein structures that mimic the organization and conformation of authentic native viruses but lack the viral genome, potentially yielding safer and cheaper vaccine candidates. Market Trends and Drivers Consistent R&D ... Read More
-
Global Gastrointestinal Rare Diseases Treatment Market Growth (Status and Outlook) 2023-2029
... Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Gastrointestinal Rare Diseases Treatment sales for 2023 through 2029. With Gastrointestinal Rare Diseases Treatment sales broken down by region, market ... Read More
-
Global Soft Tissue Sarcoma Drugs Market Growth (Status and Outlook) 2023-2029
... Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Soft Tissue Sarcoma Drugs sales for 2023 through 2029. With Soft Tissue Sarcoma Drugs sales broken down by region, market ... Read More
-
Gastroesophageal Reflux Disease (GERD) - Drug Pipeline Landscape, 2023
... erosions. Gastroesophageal reflux disease can cause due to frequent acid reflux or reflux of nonacidic content from the stomach, If the sphincter does not relax as it should or it weakens, stomach acid can flow ... Read More
-
Ophthalmology Drugs Global Market Briefing 2023
... market was $7.2 and in terms of global GDP, the market was 0.05%. Ophthalmology drugs was the ninth largest segment within the market accounting for 3.5% preceded and followed by gastrointestinal drugs and at 4.7% ... Read More
-
Pharmaceuticals Global Market Briefing 2023
... drugs was the largest segment within the pharmaceuticals market accounting for 15.5% followed by oncology drugs at 13.9% and central nervous system drugs at 11.2%. Pharmaceuticals Global Market Briefing 2023 provides strategists, marketers and senior ... Read More
-
Oncology Drugs Global Market Briefing 2023
... market was $28.5 and in terms of global GDP, the market was 0.20%. Oncology drugs was the second largest segment within the market accounting for 13.9% preceded and followed by anti-infective drugs at 15.5% and ... Read More
-
Cardiovascular Drugs Global Market Briefing 2023
... market was $19.8 and in terms of global GDP, the market was 0.14%. Cardiovascular drugs was the fifth largest segment within the market accounting for 9.6% preceded and followed by respiratory diseases drugs at 9.7% ... Read More
-
Metabolic Disorders Drugs Global Market Briefing 2023
... consumption, the market was $11.7 and in terms of global GDP, the market was 0.08%. Metabolic disorders drugs was the seventh largest segment within the market accounting for 5.7% preceded and followed by musculoskeletal disorders ... Read More
-
Anti-Infective Drugs Global Market Briefing 2023
... was $31.8 and in terms of global GDP, the market was 0.23%. Anti-infective drugs was the largest segment within the market accounting for 15.5% followed by oncology drugs at 13.9% and central nervous system drugs ... Read More
-
Genito-Urinary Drugs Global Market Briefing 2023
... market was $5.5 and in terms of global GDP, the market was 0.04%. Genito-urinary drugs was the eleventh largest segment within the market accounting for 2.6% preceded and followed by dermatology drugs at 3.4% and ... Read More
-
Respiratory Diseases Drugs Global Market Briefing 2023
... consumption, the market was $19.8 and in terms of global GDP, the market was 0.14%. Respiratory diseases drugs was the fourth largest segment within the market accounting for 9.7% preceded and followed by central nervous ... Read More
-
Hematology Drugs Global Market Briefing 2023
... market was $4.6 and in terms of global GDP, the market was 0.03%. Hematology drugs was the twelfth largest segment within the market accounting for 2.2% preceded by genito-urinary drugs at 2.6% and dermatology drugs ... Read More
-
Central Nervous System Drugs Global Market Briefing 2023
... per capita consumption, the market was $23.1 and in terms of global GDP, the market was 0.16%. Central nervous system drugs was the third largest segment within the market accounting for 11.2% preceded and followed ... Read More
-
Dermatology Drugs Global Market Briefing 2023
... market was $7.1 and in terms of global GDP, the market was 0.05%. Dermatology drugs was the tenth largest segment within the market accounting for 3.4% preceded and followed by ophthalmology drugs at 3.5% and ... Read More
-
Gastrointestinal Drugs Global Market Briefing 2023
... market was $9.7 and in terms of global GDP, the market was 0.07%. Gastrointestinal drugs was the eighth largest segment within the market accounting for 4.7% preceded and followed by metabolic disorders drugs at 5.7% ... Read More
-
Musculoskeletal Disorders Drugs Global Market Briefing 2023
... consumption, the market was $13.4 and in terms of global GDP, the market was 0.09%. Musculoskeletal disorders drugs was the sixth largest segment within the market accounting for 6.5% preceded and followed by cardiovascular drugs ... Read More
-
Crohn'S Disease Diagnostics and Therapeutics Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... With the rise in COVID-19, the prevalence of other related complications also increased. According to a report by the SECURE-IBD database in January 2022, adverse COVID-19 outcomes were associated with age and other co-morbidities among ... Read More
-
Social Anxiety Disorder (SAD) - Drug Pipeline Landscape, 2023
... environmental factors like inherited traits, brain structure (amygdala may play a role in controlling the fear response), and environment. The main symptoms of social anxiety disorders are a person's inability to work, difficulty maintaining friendships, ... Read More
-
Amyotrophic Lateral Sclerosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 969.3 Million by 2028, exhibiting a growth rate (CAGR) of 4.9% during 2023-2028. Amyotrophic Lateral Sclerosis (ALS) Treatment refers to a degenerative disease that affects the nerve cells in the spinal ... Read More
-
Epilepsy Drugs Market by Generation Type (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), Anti-Epileptics Drugs Type (Narrow-Spectrum AEDs, Broad-Spectrum AEDs), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, and Other
... epilepsy drugs market size reached US$ 2.16 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.52 Billion by 2028, exhibiting a growth rate (CAGR) of 8.2% during 2023-2028. The rising ... Read More
-
Global Hepatitis B Virus (HBV) Vaccine Market: Analysis By End User (Adult & Pediatric), By Composition (Mono & Combination), By Region (The US, China, EU+UK, Japan & ROW), Size and Trends with Impact of COVID-19 and Forecast up to 2027
... and Forecast up to 2027 The global hepatitis B virus (HBV) vaccine market was valued at US$2.23 billion in 2021, and is predicted to grow to US$3.04 billion in 2027. The hepatitis B virus (HBV) ... Read More
Research Assistance
